Your browser doesn't support javascript.
loading
The cannabinoid receptor agonist WIN55.212 reduces consequences of status epilepticus in rats.
Suleymanova, Elena M; Shangaraeva, Vitalia A; van Rijn, Clementina M; Vinogradova, Lyudmila V.
Affiliation
  • Suleymanova EM; Institute of Higher Nervous Activity and Neurophysiology Russian Academy of Sciences, Moscow, Russia.
  • Shangaraeva VA; Institute of Higher Nervous Activity and Neurophysiology Russian Academy of Sciences, Moscow, Russia.
  • van Rijn CM; Donders Institute for Brain, Cognition and Behavior, Radboud University Nijmegen, Nijmegen, The Netherlands.
  • Vinogradova LV; Institute of Higher Nervous Activity and Neurophysiology Russian Academy of Sciences, Moscow, Russia. Electronic address: lvinogradova@gmail.com.
Neuroscience ; 334: 191-200, 2016 Oct 15.
Article in En | MEDLINE | ID: mdl-27520083

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Status Epilepticus / Morpholines / Benzoxazines / Cannabinoid Receptor Agonists / Anticonvulsants / Naphthalenes Limits: Animals Language: En Journal: Neuroscience Year: 2016 Document type: Article Affiliation country: Rusia Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Status Epilepticus / Morpholines / Benzoxazines / Cannabinoid Receptor Agonists / Anticonvulsants / Naphthalenes Limits: Animals Language: En Journal: Neuroscience Year: 2016 Document type: Article Affiliation country: Rusia Country of publication: Estados Unidos